Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;35(7):1493-1504.
doi: 10.1111/jdv.17110. Epub 2021 Feb 12.

Stigma in visible skin diseases - a literature review and development of a conceptual model

Affiliations
Review

Stigma in visible skin diseases - a literature review and development of a conceptual model

N Germain et al. J Eur Acad Dermatol Venereol. 2021 Jul.

Abstract

The burden of visible skin diseases (VSDs) includes not only physical symptoms but also psychosocial consequences such as depression, anxiety, impaired quality of life and low self-esteem. Stigmatization was shown to play a major role in people with skin diseases. The aim of the study was to review the evidence for the components, drivers and impacts of (self-)stigma, and to organize the data into a series of conceptual models. A targeted literature search was conducted to identify studies on (self-)stigma in relation to VSD. Conceptual models of stigma in VSDs were developed from existing generic conceptual models for VSD and of generic conceptual models of stigma and were refined after discussion with a board of experts, patient advocacy groups, clinicians and researchers. A total of 580 references were identified, of which 56 references were analysed and summarized. Two conceptual models of stigma were identified: one with external stigma and self-stigma dimensions, the other for self-stigma in mental health. These models were adapted to allow a complete description of stigma in VSDs. For this, a distinction was made between 'discrimination' and 'impact'. Finally, five models were developed: macro-overview; stigma, impact and socio-demographics; stigma, impact and disease characteristics; stigma, impact and quality of life; and stigma, impact and coping. Gaps were identified in available quantitative evidence. To our knowledge, this is the first conceptual model of stigma in VSDs. The model will help to standardize evaluation of stigma and to enhance empirical evaluation of anti-stigma interventions in VSDs. Further research should be conducted to develop a more complete model in stigma due to significant gaps in existing evidence, particularly including the stigma in others (external stigma) and also to cover a broader range of VSDs as their impact on particular dimensions of stigma differs.

PubMed Disclaimer

References

    1. Lu Y, Dullera P, van der Valk PGM, Eversa AWM. Helplessness as predictor of perceived stigmatization in patients with psoriasis and atopic dermatitis. Dermatol Psychosom 2003; 4: 146-150.
    1. Roosta N, Black DS, Peng D, Riley LW. Skin disease and stigma in emerging adulthood: Impact on healthy development. J Cutan Med Surg 2010; 14: 285-290.
    1. Schmid-Ott G, Kuensebeck H, Jaeger B, Werfel T, Frahm K, Ruitman J et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol 1999; 79: 443-447.
    1. Porter JR, Hill Beuf A, Lerner A, Nordlund J. Psychosocial effect of vitiligo: A comparison of vitiligo patients with 'normal' control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986; 15: 220-224.
    1. Rzepa T, Jakubowicz O, Witmanowski H, Zaba R. Disease-induced level of shame in patients with acne, psoriasis and syphilis. Postepy Dermatol Alergol 2013; 30: 233-236.

Grants and funding

LinkOut - more resources